Synopsis:
The Board of Fischer Medical Ventures at its meeting held on 28th July, approved the sub-division/split in a 1:10 ratio. Record date to be announced later.
During Monday’s trading session, shares of one of the leading traders in medical equipment in India surged nearly 2.4 percent on BSE, after the company’s Board approved a stock split in a ratio of 1:10.
At 03:23 p.m., shares of Fischer Medical Ventures Limited were trading in the green at Rs. 957.1 on BSE, up by nearly 1.2 percent, as against its previous closing price of Rs. 945.6, with a market cap of Rs. 6,141.4 crores.
What’s the News
According to the latest regulatory filings with the stock exchanges, the Board of Fischer Medical Ventures Limited, at its meeting held on 28th July, approved the sub-division/split in a 1:10 ratio. This means that the existing 1 equity share with a face value of Rs. 10 each will be divided into 10 fully paid-up equity shares of face value of Re. 1 each, subject to shareholders’ approval. The record date for the stock split will be announced separately, once approval is secured through the postal ballot and e-voting process.
Financials & more
Fischer Medical Ventures reported a significant growth in its revenue from operations, showing a year-on-year rise of around 136 percent from Rs. 20.8 crores in Q4 FY24 to Rs. 49.2 crores in Q4 FY25. In contrast, its net profit decreased during the same period from Rs. 2.6 crores to Rs. 1.3 crores, representing a decline of around 50 percent YoY.
Fischer Medical Ventures Limited, formerly known as Fischer Chemic Limited, is one of the leading traders in medical equipment in India, including magnetic resonance imaging (MRI) machines. Aside from medical devices, FMV holds a diverse portfolio of diagnostic solutions tailored to multiple point-of-care diagnostic solutions.
The company has changed the nature of business from manufacturing of chemicals to trading and manufacturing of medical equipment, including MRI machines, consequent to the share subscription agreement entered by the company with Time Medical International Ventures (India) Private Limited and their Promoters in December 2024.
Written by Shivani Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
